anhedonia glp-1 glp 1 Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in GLP-1s and anhedonia: is dopamine

Various GLP-1RAs have been demonstrated to have significant benefits in in vitro and in vivo models of neurodegenerative diseases through modulating a variety of pathogenic mechanisms, including neuroinflammation, autophagy, mitochondrial dysfunction, and the abnormal phosphorylation of pathognomonic proteins

Remove patch and discard

To help navigate this shifting environment, pharma companies should consider the following imperatives: GLP1s are expanding far beyond diabetes and obesity

Ready to begin your GLP-1 weight loss journey

Why low and slow is the way to go.

Learn what GLP-1 antagonists are and explore their pros and cons